Health Products Type II Updated 2023-05-31

PMS-Pazopanib 200 mg tablet; Presence of Sorafenib

Recalled Product

PMS-Pazopanib 200 mg tablet


Hazard / Issue

Product quality

Issued by

Drugs and health products

⚠️ What You Should Do

Verify if your product is affected.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon Canada →